Literature DB >> 3024807

Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors.

W A Gelderman, H Schraffordt Koops, D T Sleijfer, J W Oosterhuis, J Marrink, H W de Bruijn, J Oldhoff.   

Abstract

Fifty-four patients with Stage I nonseminomatous testicular germ cell tumors (NSTGCT) were treated from 1982 to 1984. In 1982 and 1983, the orchidectomy was followed by an exploratory laparotomy to conclude the dissemination study. In 1984, laparotomy was performed only if indicated. The mean follow-up was 29 months. A relapse occurred in 11 patients (20%). The relapse rate in patients who underwent exploratory laparotomy was as high as that in patients who did not. All patients treated for relapse by chemotherapy and surgery entered a complete remission for at least 1 year. It proved impossible to establish criteria for prediction of a subsequent relapse. Both serum tumor marker assays and roentgenography are important aids in diagnosing a relapse. With careful follow-up of Stage I NSTGCT patients, a wait-and-see attitude can be adopted until a relapse occurs.

Entities:  

Mesh:

Year:  1987        PMID: 3024807     DOI: 10.1002/1097-0142(19870201)59:3<578::aid-cncr2820590337>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer.

Authors:  E van den Berg-de Ruiter; B de Jong; N H Mulder; G J te Meerman; H Schraffordt Koops; D T Sleijfer
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

2.  Serum lactate dehydrogenase isoenzyme 1 activity in patients with testicular germ cell tumors correlates with the total number of copies of the short arm of chromosome 12 in the tumor.

Authors:  F E von Eyben; W E de Graaff; J Marrink; O Blaabjerg; D T Sleijfer; H S Koops; J W Oosterhuis; P H Petersen; J van Echten-Arends; B de Jong
Journal:  Mol Gen Genet       Date:  1992-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.